These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 21555633)
21. [Don't let the patient with Parkinson's disease fall!]. Bloem BR; Grimbergen YA; Roos RA Ned Tijdschr Geneeskd; 1998 Dec; 142(52):2825-7. PubMed ID: 10065254 [TBL] [Abstract][Full Text] [Related]
22. Akinetic crisis, acute akinesia, neuroleptic malignant-like syndrome, Parkinsonism-hyperpyrexia syndrome, and malignant syndrome are the same entity and are often independent of treatment withdrawal. Thomas A; Onofrj M Mov Disord; 2005 Dec; 20(12):1671; author reply 1671-2. PubMed ID: 16149099 [No Abstract] [Full Text] [Related]
23. Hyperpyrexia in the emergency department. McGugan EA Emerg Med (Fremantle); 2001 Mar; 13(1):116-20. PubMed ID: 11476402 [TBL] [Abstract][Full Text] [Related]
25. Recognizing Movement Disorder Emergencies - A Practical Review For Non-Neurologist. Hakeem H; Nasir M; Khan MF; Syed NM; Rajput HM; Ahmed A; Javed MA; Bhatti DE J Ayub Med Coll Abbottabad; 2019; 31(3):448-453. PubMed ID: 31535526 [TBL] [Abstract][Full Text] [Related]
26. Behavioral, neuropsychiatric and cognitive disorders in Parkinson's disease patients with and without motor complications. Solla P; Cannas A; Floris GL; Orofino G; Costantino E; Boi A; Serra C; Marrosu MG; Marrosu F Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1009-13. PubMed ID: 21324349 [TBL] [Abstract][Full Text] [Related]
27. Psychotic symptoms in Parkinson's disease: pathophysiology and management. Bosboom JL; Wolters ECh Expert Opin Drug Saf; 2004 May; 3(3):209-20. PubMed ID: 15155149 [TBL] [Abstract][Full Text] [Related]
28. Common toxidromes in movement disorder neurology. Malek N; Baker MR Postgrad Med J; 2017 Jun; 93(1100):326-332. PubMed ID: 28546460 [TBL] [Abstract][Full Text] [Related]
29. The emerging role of clozapine in the treatment of movement disorders. Factor SA; Friedman JH Mov Disord; 1997 Jul; 12(4):483-96. PubMed ID: 9251065 [TBL] [Abstract][Full Text] [Related]
30. The neuroleptic malignant and serotonin syndromes. Carbone JR Emerg Med Clin North Am; 2000 May; 18(2):317-25, x. PubMed ID: 10767887 [TBL] [Abstract][Full Text] [Related]
32. [Rhabdomyolysis in neuroleptic therapy: an abortive malignant neuroleptic syndrome?]. Peschel O; Kurtz G; Müller-Felber W; Modell S Nervenarzt; 1994 Oct; 65(10):718-21. PubMed ID: 7808573 [TBL] [Abstract][Full Text] [Related]
33. Movement disorders with neuroleptic drug treatment. Tarsy D Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742 [TBL] [Abstract][Full Text] [Related]
34. Psychiatric Emergencies in the Intensive Care Unit. New AM; Nelson S; Leung JG AACN Adv Crit Care; 2015; 26(4):285-93; quiz 294-5. PubMed ID: 26484986 [No Abstract] [Full Text] [Related]
35. [Dantrolene in the treatment of life-threatening psychiatric disease pictures. A contribution to the therapy of the malignant neuroleptic syndrome and acute febrile catatonia]. Schulte-Sasse U; Komar K; Eberlein HJ Dtsch Med Wochenschr; 1985 Mar; 110(12):457-61. PubMed ID: 3979279 [TBL] [Abstract][Full Text] [Related]